Investigating the Effects of Wearable Robotic Exoskeleton for Improving Mobility and Cognition in Persons With MS

Conditions

• Cognitive Impairment
• Gait Disorders, Neurologic
• Motility Disorder
• Multiple Sclerosis

Eligibility Criteria

Sex

ALL

Age

18 Years - 75 Years

Healthy Volunteers

Not accepted

Interventions

• Robotic Exoskeleton Rehabilitation — DEVICE
  Participants will be randomly assigned to one of the two groups. Each participant will receive 8 sessions of gait rehabilitation and therapy via traditional therapy techniques of using the robotic exoskeleton. This training will be provided by a licensed physical therapist.
• Conventional Gait Therapy — OTHER
  Participants will be randomly assigned to one of the two groups. Each participant will receive 8 sessions of gait rehabilitation and therapy via traditional therapy techniques of using the robotic exoskeleton. This training will be provided by a licensed physical therapist.

Study Details

The purpose of this research study is to evaluate the usefulness of a wearable robotic exoskeleton device (Ekso-GT), to improve learning and memory, and gait therapy in persons with walking disability due to Multiple Sclerosis. The study will evaluate the mobility, learning and memory, and walking abilities of individuals with multiple sclerosis who went through the traditional as compared to others who used the robotic exoskeleton as part of their therapy.

Key Dates

Start date

Oct 5, 2017

Status verified

Nov 2025

Primary completion

Dec 30, 2027

Completion

Dec 30, 2027

Study Design

Enrollment

10 participants (estimated)

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Arms

• Experimental: Robotic Exoskeleton Therapy
  Gait rehabilitation provided using a wearable robotic exoskeleton
• Active Comparator: Conventional Gait Therapy
  Gait rehabilitation provided using traditional gait therapy under the supervision of a licensed PT

Primary Outcome Measure

Distance walked in a specific time duration [ Time Frame: approximately 12 weeks ]

Locations (1)

Find similar trials in West Orange, NJ

Related Studies

• Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
  PHASE1 · Recruiting · National Cancer Institute (NCI) · Birmingham, Alabama
• REpeated ASSEssment of SurvivorS in Intracerebral Hemorrhage Study
  Enrolling By Invitation · Johns Hopkins University · Birmingham, Alabama
• A Novel Combinatory Approach to Maximize Functional Recovery of Learning and Memory in Multiple Sclerosis
  Recruiting · Kessler Foundation · East Hanover, New Jersey
• A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)
  PHASE1 · Recruiting · Juno Therapeutics, Inc., a Bristol-Myers Squibb Company · Birmingham, Alabama